Serum prolactin levels and sexual dysfunctions in antipsychotic medication, such as risperidone: a review

被引:10
作者
Knegtering, H
Lambers, PA
Prakken, G
ten Brink, C
机构
[1] Acad Ziekenhuis, Groningen, Netherlands
[2] Algemeen Psychiat Ziekenhuis Drenthe, Assen, Netherlands
来源
ACTA NEUROPSYCHIATRICA | 2000年 / 12卷 / 01期
关键词
atypical antipsychotics; menstrual disturbances; prolactin; risperidone; sexual dysfunction; typical antipsychotics;
D O I
10.1017/S092427080003578X
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Classical antipsychotic drugs increase the level of serum prolactin. The atypical antipsychotic clozapine barely increases prolactin levels. An open naturalistic study in the University Hospital of Groningen suggests that treatment with risperidone in comparison to classical antipsychotics seems to increase the risk of erectile and ejaculatory disorders in male patients and to menstrual disturbances in female patients. In the literature reviewed, risperidone is associated with higher prolactin levels in comparison to classical antipsychotics. It is still unclear which mechanism is responsible for the increase of serum prolactin levels and sexual dysfunctions in patients using risperidone. Dopaminergic and serotonergic receptor blockade seems to play an important role. Other mechanisms are discussed.
引用
收藏
页码:19 / +
页数:6
相关论文
共 42 条
[1]  
AIZENBERG D, 1995, J CLIN PSYCHIAT, V56, P137
[2]  
Baldwin D S, 1997, Int J Psychiatry Clin Pract, V1, P47, DOI 10.3109/13651509709069205
[3]  
BERSANI G, 1990, Human Psychopharmacology, V5, P225, DOI 10.1002/hup.470050307
[4]  
BURSATTO GF, 1993, BRIT J PSYCHIAT, V163, P833
[5]  
BURSATTO GF, 1995, PSYCHOPHARMACOLOGY, V117, P55
[6]   Prolactin and testosterone: Their role in male sexual function [J].
Carani, C ;
Granata, ARM ;
Fustini, MF ;
Marrama, P .
INTERNATIONAL JOURNAL OF ANDROLOGY, 1996, 19 (01) :48-54
[7]   RISPERIDONE VERSUS HALOPERIDOL IN THE TREATMENT OF CHRONIC-SCHIZOPHRENIC INPATIENTS - A MULTICENTER DOUBLE-BLIND COMPARATIVE-STUDY [J].
CLAUS, A ;
BOLLEN, J ;
DECUYPER, H ;
ENEMAN, M ;
MALFROID, M ;
PEUSKENS, J ;
HEYLEN, S .
ACTA PSYCHIATRICA SCANDINAVICA, 1992, 85 (04) :295-305
[8]   5-HT2a/2c, receptor blockade by amesergide fully attenuates prolactin response to d-fenfluramine challenge in physically healthy human subjects [J].
Coccaro, EF ;
Kavoussi, RJ ;
Oakes, M ;
Cooper, TB ;
Hauger, R .
PSYCHOPHARMACOLOGY, 1996, 126 (01) :24-30
[9]  
DENBOER JA, 1996, LEERBOEK SCHIZOFRENI, P302
[10]  
DICKSON RA, 1995, AM J PSYCHIAT, V152, P1102